721Tip A Phase I/II Study of Davutamig (REGN5093), a MET×MET Bispecific Antibody, in Patients with MET-altered, Advanced Non-Small Cell Lung Cancer (ansclc): Trial in Progress Update
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined